<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="brief-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Hum Cell</journal-id><journal-id journal-id-type="iso-abbrev">Hum. Cell</journal-id><journal-title-group><journal-title>Human Cell</journal-title></journal-title-group><issn pub-type="ppub">0914-7470</issn><issn pub-type="epub">1749-0774</issn><publisher><publisher-name>Springer Singapore</publisher-name><publisher-loc>Singapore</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31975031</article-id><article-id pub-id-type="pmc">7080676</article-id><article-id pub-id-type="publisher-id">318</article-id><article-id pub-id-type="doi">10.1007/s13577-019-00318-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Rapid Communication</subject></subj-group></article-categories><title-group><article-title>A common variant of LDL receptor&#x000a0;related protein 2 (<italic>LRP2</italic>) gene is associated with gout susceptibility: a meta-analysis in a Japanese population</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Akashi</surname><given-names>Airi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Nakayama</surname><given-names>Akiyoshi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kamatani</surname><given-names>Yoichiro</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Higashino</surname><given-names>Toshihide</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Shimizu</surname><given-names>Seiko</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kawamura</surname><given-names>Yusuke</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Imoto</surname><given-names>Misaki</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Naito</surname><given-names>Mariko</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Hishida</surname><given-names>Asahi</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kawaguchi</surname><given-names>Makoto</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Takao</surname><given-names>Mikiya</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Matsuo</surname><given-names>Michinori</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Takada</surname><given-names>Tappei</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Ichida</surname><given-names>Kimiyoshi</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Ooyama</surname><given-names>Hiroshi</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Shinomiya</surname><given-names>Nariyoshi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Matsuo</surname><given-names>Hirotaka</given-names></name><address><email>hmatsuo@ndmc.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.416614.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0374 0880</institution-id><institution>Department of Integrative Physiology and Bio-Nano Medicine, </institution><institution>National Defense Medical College, </institution></institution-wrap>3-2 Namiki, Tokorozawa, Saitama 359-8513 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.7597.c</institution-id><institution-id institution-id-type="ISNI">0000000094465255</institution-id><institution>Laboratory for Statistical Analysis, </institution><institution>RIKEN Center for Integrative Medical Science, </institution></institution-wrap>Yokohama, Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.26999.3d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2151 536X</institution-id><institution>Graduate School of Frontier Sciences, </institution><institution>The University of Tokyo, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.27476.30</institution-id><institution-id institution-id-type="ISNI">0000 0001 0943 978X</institution-id><institution>Department of Preventive Medicine, </institution><institution>Nagoya University Graduate School of Medicine, </institution></institution-wrap>Nagoya, Aichi Japan </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.257022.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 8711 3200</institution-id><institution>Department of Oral Epidemiology, </institution><institution>Hiroshima University Graduate School of Biomedical and Health Sciences, </institution></institution-wrap>Hiroshima, Japan </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.411223.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 0666 1238</institution-id><institution>Department of Food and Nutrition, Faculty of Home Economics, </institution><institution>Kyoto Women&#x02019;s University, </institution></institution-wrap>Kyoto, Japan </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.412708.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1764 7572</institution-id><institution>Department of Pharmacy, </institution><institution>The University of Tokyo Hospital, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.410785.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0659 6325</institution-id><institution>Department of Pathophysiology, </institution><institution>Tokyo University of Pharmacy and Life Sciences, </institution></institution-wrap>Hachioji, Tokyo Japan </aff><aff id="Aff9"><label>9</label>Ryougoku East Gate Clinic, Tokyo, Japan </aff></contrib-group><pub-date pub-type="epub"><day>24</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="ppub"><year>2020</year></pub-date><volume>33</volume><issue>2</issue><fpage>303</fpage><lpage>307</lpage><history><date date-type="received"><day>14</day><month>11</month><year>2019</year></date><date date-type="accepted"><day>23</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Gout, which results from elevated serum uric acid (SUA), is a common form of arthritis that is induced by urate crystals. A single&#x000a0;nucleotide polymorphism, rs2544390, of LDL receptor related protein 2 (<italic>LRP2/Megalin</italic>), has previously been reported to be associated with SUA by a genome-wide association study in a Japanese population. However, it was controversial as to whether rs2544390 is associated with gout in a Japanese population, since previous studies with Japanese populations have reported an association between gout and rs2544390 both with and without significance. This prompted us to investigate the association between gout and rs2544390 of <italic>LRP2.</italic> Using 1208 clinically diagnosed gout patients and 1223 controls in a Japanese male population, our results showed that while rs2544390 did not show a significant association with gout susceptibility in the present study (<italic>p</italic>&#x02009;=&#x02009;0.0793, odds ratio [OR] with 95% confidential interval [CI] 1.11 [0.99&#x02013;1.24]). However, a meta-analysis using previous studies on Japanese populations revealed a significant association with gout (<italic>p</italic><sub>meta</sub>&#x02009;=&#x02009;0.0314, OR with 95% CI 1.09 [1.01&#x02013;1.18]). We have therefore for the first time confirmed a positive association between rs2544390 and gout with only a Japanese male population. Our study provides clues to a better understanding of the pathogenesis of gout and has the potential to lead to novel therapeutic strategies against gout using LRP2 as a molecular target.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Uric acid</kwd><kwd>Gout</kwd><kwd>Hyperuricemia</kwd><kwd>LRP2</kwd><kwd>Single&#x000a0;nucleotide polymorphism (SNP)</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Japan Human Cell Society 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Gout is a common disease that results from an increase in serum uric acid (SUA), which can lead to renal failure, hypertension, and cardiovascular disease [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. rs2544390, a single&#x000a0;nucleotide polymorphism (SNP) in LDL receptor related protein 2 (<italic>LRP2</italic>, also known as <italic>Megalin</italic>), was found to have an association with SUA in a genome-wide association study (GWAS) with 8868 Japanese [<xref ref-type="bibr" rid="CR3">3</xref>]. However, the association between rs2544390 and gout remained to be clarified, because some studies, including ours, have reported no association [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>], while others have revealed a significant association [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>]. In this study, we investigated a further association between gout and rs2544390 with clinically diagnosed gout patients and controls, and performed a meta-analysis based on past Japanese population studies [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Patients and controls</title><p id="Par3">1208 male Japanese patients were recruited from outpatients at Ryougoku East Gate Clinic (Tokyo, Japan). All these subjects had been diagnosed with primary gout according to the criteria established by the American College of Rheumatology [<xref ref-type="bibr" rid="CR8">8</xref>]. As the control group, 1223 Japanese males without a history of gout or hyperuricemia (SUA levels&#x02009;&#x0003e;&#x02009;7.0&#x000a0;mg/dL) were selected from participants in the Shizuoka area in the Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study) [<xref ref-type="bibr" rid="CR9">9</xref>]. The mean age and standard deviation of cases and controls were 45.4&#x02009;&#x000b1;&#x02009;10.4 and 53.1&#x02009;&#x000b1;&#x02009;8.8&#x000a0;years, respectively, and their mean body mass index was 25.4&#x02009;&#x000b1;&#x02009;3.7 and 23.3&#x02009;&#x000b1;&#x02009;2.7&#x000a0;kg/m<sup>2</sup>, respectively.</p></sec><sec id="Sec4"><title>Genetic and statistical analyses</title><p id="Par4">Genomic DNA was extracted from whole peripheral blood [<xref ref-type="bibr" rid="CR10">10</xref>]. Genotyping of <italic>LRP2</italic> polymorphism (rs2544390) was performed using a TaqMan assay (Custom TaqMan MGB, Applied Biosystems) with a Lightcycler 480 (Roche Diagnostics) as previously described [<xref ref-type="bibr" rid="CR4">4</xref>]. To confirm their genotypes, more than 25 samples were subjected to direct sequencing with the following primers: for rs2544390, forward 5&#x02032;-CTGTCTGAGACCATGACACAG-3&#x02032;, and reverse 5&#x02032;-CCTCACCTGTCATTGTCTTG-3&#x02032;. DNA sequencing analysis was performed with a 3130xl Genetic Analyzer (Applied Biosystems) [<xref ref-type="bibr" rid="CR11">11</xref>]. For the calculations in the statistical analyses, we used SPSS v.22.0J (IBM Japan Inc., Tokyo, Japan) and R (version 3.1.1) [<xref ref-type="bibr" rid="CR12">12</xref>] including a meta-package [<xref ref-type="bibr" rid="CR13">13</xref>]. The Chi-square test was used for the association and Hardy&#x02013;Weinberg equilibrium analyses. A <italic>p</italic> value of&#x02009;&#x0003c;&#x02009;0.05 was regarded as statistically significant.</p></sec></sec><sec id="Sec5"><title>Results</title><p id="Par5">Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> shows the genotyping results of rs2544390 for 1208 gout cases and 1223 controls. The genotyping call rate for this SNP was more than 98%. In the control group, this SNP was in Hardy&#x02013;Weinberg equilibrium (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05), which suggested no mistyping.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Association between gout and <italic>LRP2</italic> rs2544390 polymorphism</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="3">Genotype</th><th align="left" rowspan="2">MAF<sup>a</sup></th><th align="left" colspan="2">Allele frequency mode</th></tr><tr><th align="left">C/C</th><th align="left">C/T</th><th align="left">T/T</th><th align="left"><italic>p</italic> value<sup>b</sup></th><th align="left">OR (95% CI)</th></tr></thead><tbody><tr><td align="left">Case</td><td char="." align="char">291</td><td char="." align="char">587</td><td char="." align="char">330</td><td char="." align="char">0.516</td><td char="." align="char">0.0793</td><td align="left">1.11 (0.99&#x02013;1.24)</td></tr><tr><td align="left">Control</td><td char="." align="char">312</td><td char="." align="char">608</td><td char="." align="char">290</td><td char="." align="char">0.491</td><td align="left"/><td align="left"/></tr></tbody></table><table-wrap-foot><p><italic>MAF</italic> minor allele frequency, <italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p><p><sup>a</sup>T: minor allele</p><p><sup>b</sup>Chi-square test of rs2544390 polymorphism</p></table-wrap-foot></table-wrap></p><p id="Par6">As in our previous study [<xref ref-type="bibr" rid="CR4">4</xref>], rs2544390 did not show a significant association with gout susceptibility (<italic>p</italic>&#x02009;=&#x02009;0.0793, odds ratio [OR] with 95% confidential interval [CI] 1.11 [0.99&#x02013;1.24]: Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The frequency of the minor risk allele, which in this study was the T allele of rs2544390, in the gout cases (51.6%) was higher than in the controls (49.1%). However, a meta-analysis including previous studies [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR6">6</xref>] with a Japanese population showed a significant association with gout (<italic>p</italic><sub>meta</sub>&#x02009;=&#x02009;0.0314, OR with 95% CI 1.09 [1.01&#x02013;1.18]; Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>A meta-analysis of rs2544390 of <italic>LRP2</italic> for gout in the Japanese male population. The meta-analysis was conducted using the present study and two previous studies of Japanese male populations (Urano et al. [<xref ref-type="bibr" rid="CR3">3</xref>] and Nakayama et al. [<xref ref-type="bibr" rid="CR5">5</xref>]). The OR in the meta-analysis was 1.09 (95% CI 1.01&#x02013;1.18) and was statistically significant (<italic>p</italic><sub>meta</sub>&#x02009;=&#x02009;0.0314), indicating a significant association between gout and the <italic>LRP2</italic> gene. <italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p></caption><graphic xlink:href="13577_2019_318_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec6"><title>Discussion</title><p id="Par7">We confirmed that rs2544390, an SNP of <italic>LRP2</italic>, has an association with gout in the Japanese population. LRP2 is a member of the low-density lipoprotein receptor [LDLR (MIM606945)] gene family and has been suggested to mediate the endocytosis of multiple ligands [<xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par8">The association between rs2544390 and SUA was first identified by a GWAS of SUA in a Japanese population by Kamatani et al [<xref ref-type="bibr" rid="CR3">3</xref>]; this was also confirmed by the recent genome-wide meta-analysis of SUA [<xref ref-type="bibr" rid="CR15">15</xref>]. Since the association between <italic>LRP2</italic> and SUA was reported, several association studies for the Japanese population have been conducted, because gout is a consequence of hyperuricemia. From Japanese male populations, Urano et al. [<xref ref-type="bibr" rid="CR6">6</xref>] reported a positive association between gout and rs2544390 (<italic>p</italic>&#x02009;=&#x02009;0.0250, OR with 95% CI 1.32 [1.03&#x02013;1.69]) in 153 gout cases and 532 controls, whereas Nakayama et al. [<xref ref-type="bibr" rid="CR4">4</xref>] reported no association with gout (<italic>p</italic>&#x02009;=&#x02009;0.758, OR with 95% CI 1.02 [0.90&#x02013;1.16]) in 741 gout cases and 1302 controls. It therefore remained an open question as to whether rs2544390 has an association with gout in the Japanese population.</p><p id="Par9">In other studies with non-Japanese populations, Dong et al. [<xref ref-type="bibr" rid="CR7">7</xref>] showed a positive association with a Chinese male population of 483 gout cases and 389 controls (<italic>p</italic>&#x02009;=&#x02009;0.020, OR with 95% CI 1.26 [1.03&#x02013;1.53]). Furthermore, their meta-analysis with the results of Nakayama et al. [<xref ref-type="bibr" rid="CR4">4</xref>] and Urano et al. [<xref ref-type="bibr" rid="CR6">6</xref>] revealed a positive association with gout (<italic>p</italic>&#x02009;=&#x02009;0.019, OR with 95% CI 1.13 [1.02&#x02013;1.24]) [<xref ref-type="bibr" rid="CR7">7</xref>], which is consistent with the conclusions of our present study. Another study from New Zealand by Rasheed et al. [<xref ref-type="bibr" rid="CR5">5</xref>] with 1431 gout cases and 1205 controls showed a negative association between rs2544390 and gout of all the participants including European Caucasian (<italic>p&#x02009;</italic>=&#x02009;0.360, OR with 95% CI 1.06 [0.94&#x02013;1.18]), in contrast to a sub-analysis of only populations of M&#x00101;ori and Pacific ancestry (<italic>p</italic>&#x02009;=&#x02009;0.0090, OR with 95% CI 1.20 [1.05&#x02013;1.38]). These results suggest there to be ethnic differences for gout risk due to the <italic>LRP2</italic> variant and that Asia-Pacific populations should show a positive association between them.</p><p id="Par10">Nakayama et al. [<xref ref-type="bibr" rid="CR4">4</xref>], who previously reported no association between rs2544390 and gout, pointed out the need for further analysis with a greater number of samples to demonstrate any significant association between the <italic>LRP2</italic> variant in question and gout. While the present association study also showed no association, our meta-analysis with a greater number of samples showed a significant positive association between rs2544390 and gout in the Japanese population.</p><p id="Par11">In the present study, we have confirmed for the first time a significant positive association between rs2544390 and gout, which has been shown in other populations by Dong et al. [<xref ref-type="bibr" rid="CR7">7</xref>] and Rasheed et al. [<xref ref-type="bibr" rid="CR5">5</xref>], in a Japanese population.</p><p id="Par12">SUA levels are regulated by urate transporters that are expressed in the kidney and intestines. Recent GWASs of clinically defined gout have revealed associations between gout and urate transporter genes, such as <italic>ABCG2/BCRP, URAT1/SLC22A12, GLUT9/SLC2A9, NPT1/SLC17A1</italic> [<xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>], all of which are expressed in the proximal tubular cells of the kidney [<xref ref-type="bibr" rid="CR17">17</xref>]. Common variants of the urate excretion transporter <italic>ABCG2</italic> are known to significantly elevate gout/hyperuricemia susceptibility and are a major cause of early onset gout [<xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref>]. ABCG2 is expressed in the human intestine and is associated with intestinal urate excretion in addition to renal urate excretion [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Furthermore, some association analyses have also shown associations between gout and urate transporter genes <italic>URAT1</italic> [<xref ref-type="bibr" rid="CR25">25</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>], <italic>NPT1</italic> [<xref ref-type="bibr" rid="CR27">27</xref>&#x02013;<xref ref-type="bibr" rid="CR29">29</xref>], <italic>OAT4/SLC22A11</italic> [<xref ref-type="bibr" rid="CR30">30</xref>] and <italic>OAT10/SLC22A13</italic> [<xref ref-type="bibr" rid="CR31">31</xref>], and scaffold protein genes <italic>PDZK1</italic> [<xref ref-type="bibr" rid="CR32">32</xref>] and <italic>LRRC16A</italic> [<xref ref-type="bibr" rid="CR33">33</xref>], which bind to various transporters and form transportosomes with them. These genes, including urate transporter genes which are associated with SUA and gout/hyperuricemia, are mostly seen in the kidney, which is one of the urate-excreting organs. The <italic>LRP2</italic> gene is also strongly expressed in the kidney [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>].</p><p id="Par13">In conclusion, the association between a mutation of <italic>LRP2</italic> and gout is confirmed in addition to association with SUA. <italic>LRP2</italic> is thought to have a possible association with urate regulation and gout susceptibility by playing an important role in urate mobilization via endocytosis. The clarification of the association between <italic>LRP2</italic> and gout progression will lead to a better understanding of the molecular pathogenesis of gout and to novel therapeutic strategies against gout, using LRP2 as a molecular target. Our new insights into LRP2 have the potential to assist with the development of future personalized medicine.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Airi Akashi and Akiyoshi Nakayama contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors would like to thank all the participants for their generous contributions to this study. We are also grateful to members of the Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study) for their support. We are indebted to K. Gotanda, Y. Morimoto, M. Miyazawa and M. Takahashi for genetic analyses, T. Nakamura and M. Sakiyama for statistical analyses, and K. Ooyama, N. Hamajima, and K. Wakai for sample collection. This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, including JSPS Kakenhi Grants (Nos. 16H06279, 16H01808, 17H04128, 18KK0247, 19K22786, and 25293145) and Grants-in-Aid for Scientific Research in Innovative Areas (No. 221S0002), the Ministry of Defense, the Kawano Masanori Memorial Foundation for Promotion of Pediatrics, and the Gout Research Foundation of Japan. The J-MICC Study was supported by Grants-in-Aid for Scientific Research from MEXT, including those for Priority Areas (No. 17015018) and Innovative Areas (No. 221S0001), as well as by JSPS Kakenhi Grant No. 16H06277.</p></ack><notes notes-type="ethics"><title>Compliance with ethical standards</title><notes notes-type="COI-statement"><title>Conflict of interest</title><p id="Par14">The authors declare that they have no conflicts of interest.</p></notes><notes><title>Ethical approval</title><p id="Par15">This study was approved by the institutional ethical committees of National Defense Medical College (No. 2914) and Nagoya University (No. 2011-1248-7). All procedures were performed in accordance with the Declaration of Helsinki and its later amendments.</p></notes><notes><title>Informed consent</title><p id="Par16">A written informed consent was obtained from each subject participating in the study.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feig</surname><given-names>DI</given-names></name><name><surname>Kang</surname><given-names>DH</given-names></name><name><surname>Johnson</surname><given-names>RJ</given-names></name></person-group><article-title>Uric acid and cardiovascular risk</article-title><source>N Engl J Med</source><year>2008</year><volume>359</volume><issue>17</issue><fpage>1811</fpage><lpage>1821</lpage><pub-id pub-id-type="pmid">18946066</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalbeth</surname><given-names>N</given-names></name><name><surname>Choi</surname><given-names>HK</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Khanna</surname><given-names>PP</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Perez-Ruiz</surname><given-names>F</given-names></name><etal/></person-group><source>Gout Nat Rev Dis Primers</source><year>2019</year><volume>5</volume><issue>1</issue><fpage>69</fpage><pub-id pub-id-type="pmid">31558729</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamatani</surname><given-names>Y</given-names></name><name><surname>Matsuda</surname><given-names>K</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Hosono</surname><given-names>N</given-names></name><name><surname>Daigo</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Genome-wide association study of hematological and biochemical traits in a Japanese population</article-title><source>Nat Genet</source><year>2010</year><volume>42</volume><issue>3</issue><fpage>210</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">20139978</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>A</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name><name><surname>Takada</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Common variants of a urate-associated gene <italic>LRP2</italic> are not associated with gout susceptibility</article-title><source>Rheumatol Int</source><year>2014</year><volume>34</volume><issue>4</issue><fpage>473</fpage><lpage>476</lpage><pub-id pub-id-type="pmid">24366390</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasheed</surname><given-names>H</given-names></name><name><surname>Phipps-Green</surname><given-names>A</given-names></name><name><surname>Topless</surname><given-names>R</given-names></name><name><surname>Hollis-Moffatt</surname><given-names>JE</given-names></name><name><surname>Hindmarsh</surname><given-names>JH</given-names></name><name><surname>Franklin</surname><given-names>C</given-names></name><etal/></person-group><article-title>Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption</article-title><source>Arthritis Res Ther</source><year>2013</year><volume>15</volume><issue>6</issue><fpage>R177</fpage><pub-id pub-id-type="pmid">24286387</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urano</surname><given-names>W</given-names></name><name><surname>Taniguchi</surname><given-names>A</given-names></name><name><surname>Inoue</surname><given-names>E</given-names></name><name><surname>Sekita</surname><given-names>C</given-names></name><name><surname>Ichikawa</surname><given-names>N</given-names></name><name><surname>Koseki</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Effect of genetic polymorphisms on development of gout</article-title><source>J Rheumatol</source><year>2013</year><volume>40</volume><issue>8</issue><fpage>1374</fpage><lpage>1378</lpage><pub-id pub-id-type="pmid">23729800</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Qian</surname><given-names>Q</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Common variants in LRP2 and COMT genes affect the susceptibility of gout in a Chinese population</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><issue>7</issue><fpage>e0131302</fpage><pub-id pub-id-type="pmid">26147675</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>SL</given-names></name><name><surname>Robinson</surname><given-names>H</given-names></name><name><surname>Masi</surname><given-names>AT</given-names></name><name><surname>Decker</surname><given-names>JL</given-names></name><name><surname>McCarty</surname><given-names>DJ</given-names></name><name><surname>Yu</surname><given-names>TF</given-names></name></person-group><article-title>Preliminary criteria for the classification of the acute arthritis of primary gout</article-title><source>Arthritis Rheum</source><year>1977</year><volume>20</volume><issue>3</issue><fpage>895</fpage><lpage>900</lpage><pub-id pub-id-type="pmid">856219</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamajima</surname><given-names>N</given-names></name><collab>J-MICC Study Group</collab></person-group><article-title>The Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study) to detect gene-environment interactions for cancer</article-title><source>Asian Pac J Cancer Prev</source><year>2007</year><volume>8</volume><issue>2</issue><fpage>317</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">17696755</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>A</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name><name><surname>Ogata</surname><given-names>H</given-names></name><name><surname>Takada</surname><given-names>Y</given-names></name><name><surname>Nakashima</surname><given-names>H</given-names></name><etal/></person-group><article-title>Common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility</article-title><source>Hum Cell</source><year>2013</year><volume>26</volume><issue>4</issue><fpage>133</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">23990105</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiba</surname><given-names>T</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Sakiyama</surname><given-names>M</given-names></name><name><surname>Nakayama</surname><given-names>A</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Wakai</surname><given-names>K</given-names></name><etal/></person-group><article-title>Common variant of ALPK1 is not associated with gout: a replication study</article-title><source>Hum Cell</source><year>2015</year><volume>28</volume><issue>1</issue><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">25326865</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Development Core Team</surname><given-names>R</given-names></name></person-group><source>R: A language and environment for statistical computing</source><year>2006</year><publisher-loc>Vienna</publisher-loc><publisher-name>R. Foundation for Statistical Computing</publisher-name></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Schwarzer</surname><given-names>G</given-names></name></person-group><source>Meta: meta-analysis with R</source><year>2014</year><publisher-loc>Berlin</publisher-loc><publisher-name>Springer</publisher-name></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marzolo</surname><given-names>MP</given-names></name><name><surname>Farfan</surname><given-names>P</given-names></name></person-group><article-title>New insights into the roles of megalin/LRP2 and the regulation of its functional expression</article-title><source>Biol Res</source><year>2011</year><volume>44</volume><issue>1</issue><fpage>89</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">21720686</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakatochi</surname><given-names>M</given-names></name><name><surname>Kanai</surname><given-names>M</given-names></name><name><surname>Nakayama</surname><given-names>A</given-names></name><name><surname>Hishida</surname><given-names>A</given-names></name><name><surname>Kawamura</surname><given-names>Y</given-names></name><name><surname>Ichihara</surname><given-names>S</given-names></name><etal/></person-group><article-title>Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals</article-title><source>Commun Biol</source><year>2019</year><volume>2</volume><issue>1</issue><fpage>115</fpage><pub-id pub-id-type="pmid">30993211</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Nakaoka</surname><given-names>H</given-names></name><name><surname>Nakayama</surname><given-names>A</given-names></name><name><surname>Sakiyama</surname><given-names>M</given-names></name><name><surname>Chiba</surname><given-names>T</given-names></name><etal/></person-group><article-title>Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes</article-title><source>Ann Rheum Dis</source><year>2016</year><volume>75</volume><issue>4</issue><fpage>652</fpage><lpage>659</lpage><pub-id pub-id-type="pmid">25646370</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>A</given-names></name><name><surname>Nakaoka</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Sakiyama</surname><given-names>M</given-names></name><name><surname>Shaukat</surname><given-names>A</given-names></name><name><surname>Toyoda</surname><given-names>Y</given-names></name><etal/></person-group><article-title>GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes</article-title><source>Ann Rheum Dis</source><year>2017</year><volume>76</volume><issue>5</issue><fpage>869</fpage><lpage>877</lpage><pub-id pub-id-type="pmid">27899376</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>SJ</given-names></name><name><surname>Tsai</surname><given-names>MH</given-names></name><name><surname>Ko</surname><given-names>YC</given-names></name><name><surname>Tsai</surname><given-names>PC</given-names></name><name><surname>Chen</surname><given-names>CJ</given-names></name><name><surname>Lai</surname><given-names>HM</given-names></name></person-group><article-title>The cyclic GMP-dependent protein kinase II gene associates with gout disease: identified by genome-wide analysis and case-control study</article-title><source>Ann Rheum Dis</source><year>2009</year><volume>68</volume><issue>7</issue><fpage>1213</fpage><lpage>1219</lpage><pub-id pub-id-type="pmid">18678579</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name><etal/></person-group><article-title>Genome-wide association analysis identifies three new risk loci for gout arthritis in Han Chinese</article-title><source>Nat Commun</source><year>2015</year><volume>6</volume><fpage>7041</fpage><pub-id pub-id-type="pmid">25967671</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Takada</surname><given-names>T</given-names></name><name><surname>Ichida</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Nakayama</surname><given-names>A</given-names></name><name><surname>Ikebuchi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population</article-title><source>Sci Transl Med</source><year>2009</year><volume>1</volume><issue>5</issue><fpage>5ra11</fpage><pub-id pub-id-type="pmid">20368174</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodward</surname><given-names>OM</given-names></name><name><surname>Kottgen</surname><given-names>A</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Guggino</surname><given-names>WB</given-names></name><name><surname>Kottgen</surname><given-names>M</given-names></name></person-group><article-title>Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout</article-title><source>Proc Natl Acad Sci USA</source><year>2009</year><volume>106</volume><issue>25</issue><fpage>10338</fpage><lpage>10342</lpage><pub-id pub-id-type="pmid">19506252</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Ichida</surname><given-names>K</given-names></name><name><surname>Takada</surname><given-names>T</given-names></name><name><surname>Nakayama</surname><given-names>A</given-names></name><name><surname>Nakashima</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><etal/></person-group><article-title>Common dysfunctional variants in <italic>ABCG2</italic> are a major cause of early-onset gout</article-title><source>Sci Rep</source><year>2013</year><volume>3</volume><fpage>2014</fpage><pub-id pub-id-type="pmid">23774753</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Nakayama</surname><given-names>A</given-names></name><name><surname>Sakiyama</surname><given-names>M</given-names></name><name><surname>Chiba</surname><given-names>T</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Kawamura</surname><given-names>Y</given-names></name><etal/></person-group><article-title>ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload</article-title><source>Sci Rep</source><year>2014</year><volume>4</volume><fpage>3755</fpage><pub-id pub-id-type="pmid">24441388</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichida</surname><given-names>K</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Takada</surname><given-names>T</given-names></name><name><surname>Nakayama</surname><given-names>A</given-names></name><name><surname>Murakami</surname><given-names>K</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name><etal/></person-group><article-title>Decreased extra-renal urate excretion is a common cause of hyperuricemia</article-title><source>Nat Commun</source><year>2012</year><volume>3</volume><fpage>764</fpage><pub-id pub-id-type="pmid">22473008</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>A</given-names></name><name><surname>Urano</surname><given-names>W</given-names></name><name><surname>Yamanaka</surname><given-names>M</given-names></name><name><surname>Yamanaka</surname><given-names>H</given-names></name><name><surname>Hosoyamada</surname><given-names>M</given-names></name><name><surname>Endou</surname><given-names>H</given-names></name><etal/></person-group><article-title>A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout</article-title><source>Arthritis Rheum</source><year>2005</year><volume>52</volume><issue>8</issue><fpage>2576</fpage><lpage>2577</lpage><pub-id pub-id-type="pmid">16059895</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakiyama</surname><given-names>M</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Nakashima</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Nakayama</surname><given-names>A</given-names></name><etal/></person-group><article-title>The effects of URAT1/SLC22A12 nonfunctional variants, R90H and W258X, on serum uric acid levels and gout/hyperuricemia progression</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>20148</fpage><pub-id pub-id-type="pmid">26821810</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phipps-Green</surname><given-names>AJ</given-names></name><name><surname>Merriman</surname><given-names>ME</given-names></name><name><surname>Topless</surname><given-names>R</given-names></name><name><surname>Altaf</surname><given-names>S</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Franklin</surname><given-names>C</given-names></name><etal/></person-group><article-title>Twenty-eight loci that influence serum urate levels: analysis of association with gout</article-title><source>Ann Rheum Dis</source><year>2016</year><volume>75</volume><issue>1</issue><fpage>124</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">25187157</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urano</surname><given-names>W</given-names></name><name><surname>Taniguchi</surname><given-names>A</given-names></name><name><surname>Anzai</surname><given-names>N</given-names></name><name><surname>Inoue</surname><given-names>E</given-names></name><name><surname>Kanai</surname><given-names>Y</given-names></name><name><surname>Yamanaka</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout</article-title><source>Ann Rheum Dis</source><year>2010</year><volume>69</volume><issue>6</issue><fpage>1232</fpage><lpage>1234</lpage><pub-id pub-id-type="pmid">19556210</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiba</surname><given-names>T</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Kawamura</surname><given-names>Y</given-names></name><name><surname>Nagamori</surname><given-names>S</given-names></name><name><surname>Nishiyama</surname><given-names>T</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><etal/></person-group><article-title>NPT1/SLC17A1 is a renal urate exporter in humans and its common gain-of-function variant decreases the risk of renal underexcretion gout</article-title><source>Arthritis Rheumatol</source><year>2015</year><volume>67</volume><issue>1</issue><fpage>281</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">25252215</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakiyama</surname><given-names>M</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Nakashima</surname><given-names>H</given-names></name><name><surname>Nakayama</surname><given-names>A</given-names></name><name><surname>Chiba</surname><given-names>T</given-names></name><etal/></person-group><article-title>A common variant of organic anion transporter 4 (<italic>OAT4/SLC22A11</italic>) gene is associated with renal underexcretion type gout</article-title><source>Drug Metab Pharmacokinet</source><year>2014</year><volume>29</volume><issue>2</issue><fpage>208</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">24025986</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higashino</surname><given-names>T</given-names></name><name><surname>Morimoto</surname><given-names>K</given-names></name><name><surname>Nakaoka</surname><given-names>H</given-names></name><name><surname>Toyoda</surname><given-names>Y</given-names></name><name><surname>Kawamura</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Dysfuctional missense variant of <italic>OAT10/SLC22A13</italic> decreases gout risk and serum uric acid levels</article-title><source>Ann Rheum Dis</source><year>2020</year><volume>79</volume><fpage>164</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">31780526</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higashino</surname><given-names>T</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Sakiyama</surname><given-names>M</given-names></name><name><surname>Nakayama</surname><given-names>A</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Takada</surname><given-names>T</given-names></name><etal/></person-group><article-title>Common variant of PDZ domain containing 1 (PDZK1) gene is associated with gout susceptibility: a replication study and meta-analysis in Japanese population</article-title><source>Drug Metab Pharmacokinet</source><year>2016</year><volume>31</volume><issue>6</issue><fpage>464</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">27720648</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakiyama</surname><given-names>M</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Chiba</surname><given-names>T</given-names></name><name><surname>Nakayama</surname><given-names>A</given-names></name><name><surname>Takada</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility</article-title><source>Hum Cell</source><year>2014</year><volume>27</volume><issue>1</issue><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">24318514</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlen</surname><given-names>M</given-names></name><name><surname>Fagerberg</surname><given-names>L</given-names></name><name><surname>Hallstrom</surname><given-names>BM</given-names></name><name><surname>Lindskog</surname><given-names>C</given-names></name><name><surname>Oksvold</surname><given-names>P</given-names></name><name><surname>Mardinoglu</surname><given-names>A</given-names></name><etal/></person-group><article-title>Proteomics. Tissue-based map of the human proteome</article-title><source>Science</source><year>2015</year><volume>347</volume><issue>6220</issue><fpage>1260419</fpage><pub-id pub-id-type="pmid">25613900</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlen</surname><given-names>M</given-names></name><name><surname>Oksvold</surname><given-names>P</given-names></name><name><surname>Fagerberg</surname><given-names>L</given-names></name><name><surname>Lundberg</surname><given-names>E</given-names></name><name><surname>Jonasson</surname><given-names>K</given-names></name><name><surname>Forsberg</surname><given-names>M</given-names></name><etal/></person-group><article-title>Towards a knowledge-based human protein atlas</article-title><source>Nat Biotechnol</source><year>2010</year><volume>28</volume><issue>12</issue><fpage>1248</fpage><lpage>1250</lpage><pub-id pub-id-type="pmid">21139605</pub-id></element-citation></ref></ref-list></back></article>